SPC 1
Latest Information Update: 28 Nov 2002
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 19 Jan 2000 Preclinical development for Pain in USA (Unknown route)